被引量: 1发表: 2010年 Method and Apparatus for Classification and Prediction of Pathology Stage using Decision Tree for Treatment of Prostate Cancer The present invention relates to a pathological stage prediction for prostate cancer treatment, and more particularly, to a prediction apparatus using a...
Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment: evidence of favorable survival in patients with diploid tumors. Cancer 1992;70:311-23.ZINCKE H, BERGSTRALH EJ, LARSON-KELLER JJ et al.: Stage D1 prostate cancer treated by radical prostatectomy and ...
Prostate cancer treatment outcomes data center stage. (cover story)The article discusses results of several studies on the new methods of prostate cancer treatment. The development of robot-assisted prostatectomy had encouraged urologists who are interested to shift in using the technique because it ...
The D'Amico risk group classification was originally developed to estimate the risk of biochemical recurrence following treatment for localized prostate ca... SA Boorjian,RJ Karnes,LJ Rangel,... - 《Journal of Urology》 被引量: 450发表: 2008年 Outcome of prostate cancer patients with initial ...
Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Objective: To report on the long-term results of high-intensity focused ultrasound in the treatment of localized prostate cancer. Methods: A total of 517 ... T Uchida,S Shoji,M Na...
Buffett said he will begin a two-month treatment of daily radiation in mid-July. During this time, he will restrict his travel but does not plan to change his daily routine otherwise. "I feel great — as if I were in my normal excellent health — and my energy level is 100 percent,...
Billionaire businessman Warren Buffet, 81, told his shareholders on Tuesday afternoon that he has been diagnosed with stage 1 prostate cancer. Buffet said his doctors told him his condition “is not remotely life-threatening or even debilitating in any meaningful way.” Buffet, the CEO and chairm...
Understanding how the QoL changes in relation with the selected treatment option can be important to the urologist and individual patient to have realistic expectations as well as to optimise treatment decisions for the prostate cancer patient when exist several alternatives. 展开 关键词: cancer stage...
Neoadjuvant and concurrent androgen deprivation therapy (ncADT) is recommended for men with high-risk prostate cancer, but not low-risk cancer or short life expectancy. It is unclear whether the use of ncADT among older men in the community setting is aligned with the potential for clinical ben...
Question: Will pelvic floor muscle training improve urinary and bowel outcomes in men receiving radiotherapy with or without hormone therapy treatment for prostate cancer? Design: RCT Pilot study with blinded assessment and randomised allocation. Participants: 40 men with early stage localised prostate ca...